Patent 7438918 was granted and assigned to University of Iowa on October, 2008 by the United States Patent and Trademark Office.
The invention provides lipid A deficient mutant Neisseria meningitidis cells, pharmaceutical compositions incorporating such cells, and methods of using such cells.